[HTML][HTML] RUNX1 haploinsufficiency results in granulocyte colony-stimulating factor hypersensitivity

DWL Chin, M Sakurai, GSS Nah, L Du, B Jacob… - Blood cancer …, 2016 - nature.com
DWL Chin, M Sakurai, GSS Nah, L Du, B Jacob, T Yokomizo, T Matsumura, T Suda…
Blood cancer journal, 2016nature.com
RUNX1/AML1 is among the most commonly mutated genes in human leukemia.
Haploinsufficiency of RUNX1 causes familial platelet disorder with predisposition to myeloid
malignancies (FPD/MM). However, the molecular mechanism of FPD/MM remains unknown.
Here we show that murine Runx1+/− hematopoietic cells are hypersensitive to granulocyte
colony-stimulating factor (G-CSF), leading to enhanced expansion and mobilization of
stem/progenitor cells and myeloid differentiation block. Upon G-CSF stimulation, Runx1+ …
Abstract
RUNX1/AML1 is among the most commonly mutated genes in human leukemia. Haploinsufficiency of RUNX1 causes familial platelet disorder with predisposition to myeloid malignancies (FPD/MM). However, the molecular mechanism of FPD/MM remains unknown. Here we show that murine Runx1+/− hematopoietic cells are hypersensitive to granulocyte colony-stimulating factor (G-CSF), leading to enhanced expansion and mobilization of stem/progenitor cells and myeloid differentiation block. Upon G-CSF stimulation, Runx1+/− cells exhibited a more pronounced phosphorylation of STAT3 as compared with Runx1+/+ cells, which may be due to reduced expression of Pias3, a key negative regulator of STAT3 signaling, and reduced physical sequestration of STAT3 by RUNX1. Most importantly, blood cells from a FPD patient with RUNX1 mutation exhibited similar G-CSF hypersensitivity. Taken together, Runx1 haploinsufficiency appears to predispose FPD patients to MM by expanding the pool of stem/progenitor cells and blocking myeloid differentiation in response to G-CSF.
nature.com